Living with IPF and Navigating the Changes
Living with any life-threatening illness is difficult and brings many changes, both to the patient and her family. Following my diagnosis of ... Read more
Updates
-
-
Researchers Discover New Targets to Inhibit Pulmonary Fibrosis
Researchers have uncovered an immunological mechanism that underlies fibrosis in different lung conditions, including sarcoidosis and idiopathic pulmonary fibrosis (IPF), a study reports. In mouse models ... Read more -
Let’s Treat Ourselves with Kindness
A pulmonary fibrosis diagnosis is difficult, to say the least. You need kindness, not just for others, but also for yourself. It helps ... Read more -
Pharmaxis’ LOXL2 Inhibitor Shows Positive Results in Phase 1 Trial in Healthy Volunteers
Pharmaxis’ first small molecule inhibitor of LOXL2 (lysyl oxidase like 2), an enzyme that promotes fibrosis in the lungs of idiopathic pulmonary fibrosis (IPF) ... Read more -
Forming Meaningful Friendships with a Chronic Illness
For as long as I can remember, I’ve always loved meeting new people. My siblings and I each have unique talents. One of my ... Read more
-
Living with IPF and Navigating the Changes
Living with any life-threatening illness is difficult and brings many changes, both to the ... -
Researchers Discover New Targets to Inhibit Pulmonary Fibrosis
Researchers have uncovered an immunological mechanism that underlies fibrosis in different lung conditions, including sarcoidosis and idiopathic ... -
Let’s Treat Ourselves with Kindness
A pulmonary fibrosis diagnosis is difficult, to say the least. You need kindness, not ... -
Pharmaxis’ LOXL2 Inhibitor Shows Positive Results in Phase 1 Trial in Healthy Volunteers
Pharmaxis’ first small molecule inhibitor of LOXL2 (lysyl oxidase like 2), an enzyme that ... -
Forming Meaningful Friendships with a Chronic Illness
For as long as I can remember, I’ve always loved meeting new people. My ... -
Analysis of Phase 3 Trial Data Shows Benefits of Esbriet for More Advanced IPF Patients
Treatment with Esbriet (pirfenidone) can effectively benefit patients with idiopathic pulmonary fibrosis (IPF) who ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests
News Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more